BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 23022987)

  • 1. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
    Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
    Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
    Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
    Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
    Schmidt HH
    Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
    [No Abstract]   [Full Text] [Related]  

  • 5. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.
    Barrett R; Morash B; Roback D; Pambrun C; Marfleet L; Ketterling RP; Harrison K; Berman JN
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
    Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C
    Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
    Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
    Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
    Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
    Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
    Serrano E; Carnicer MJ; Lasa A; Orantes V; Pena J; Brunet S; Aventín A; Sierra J; Nomdedéu JF
    Leuk Res; 2008 Jun; 32(6):944-53. PubMed ID: 18206229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
    Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
    Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
    Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).
    Yin JY; Tang Q; Qian W; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
    Int J Clin Exp Pathol; 2014; 7(11):8032-8. PubMed ID: 25550847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
    Panagopoulos I; Fioretos T; Isaksson M; Mitelman F; Johansson B; Theorin N; Juliusson G
    Genes Chromosomes Cancer; 2002 Dec; 35(4):372-4. PubMed ID: 12378533
    [No Abstract]   [Full Text] [Related]  

  • 19. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.
    Vizmanos JL; Larráyoz MJ; Lahortiga I; Floristán F; Alvarez C; Odero MD; Novo FJ; Calasanz MJ
    Genes Chromosomes Cancer; 2003 Apr; 36(4):402-5. PubMed ID: 12619164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.
    Gervais C; Murati A; Helias C; Struski S; Eischen A; Lippert E; Tigaud I; Penther D; Bastard C; Mugneret F; Poppe B; Speleman F; Talmant P; VanDen Akker J; Baranger L; Barin C; Luquet I; Nadal N; Nguyen-Khac F; Maarek O; Herens C; Sainty D; Flandrin G; Birnbaum D; Mozziconacci MJ; Lessard M;
    Leukemia; 2008 Aug; 22(8):1567-75. PubMed ID: 18528428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.